Abstract Background Major Depressive Disorder (MDD) is a heterogeneous disease
characterized by emotional, physical and cognitive symptoms. This study explored the …

Background: Management of cognitive deficits in Major Depressive Disorder (MDD) remains
an important unmet need. This meta-analysis evaluated the effects of vortioxetine on …

Abstract Background Major Depressive Disorder (MDD) is a complex disease characterized
by emotional, physical and cognitive symptoms. We explored the efficacy of vortioxetine …

Background Functional recovery is an important treatment goal in major depressive disorder
(MDD). This study assessed the real-world effectiveness of vortioxetine in patients with …

The efficacy of vortioxetine 10 and 20 mg/d vs. placebo on cognitive function and depression
in adults with recurrent moderate-to-severe major depressive disorder (MDD) was …

This multicenter, randomized, double-blind, placebo-controlled, active-referenced
(duloxetine 60 mg), parallel-group study evaluated the short-term efficacy and safety of …

Background Dementia and depression are increasingly common worldwide, and their
effective control could ease the burden on economies, public health systems, and support …

Objective: This post hoc analysis investigates the effect of vortioxetine on cognitive
functioning and depressive symptoms in working adults with major depressive disorder …

Background With symptomatic remission and functional recovery as the overarching
therapeutic objectives of antidepressant therapy, composite endpoint measures that …

Background: These post hoc analyses evaluated vortioxetine efficacy on cognitive
dysfunction in depression. Data were from a double-blind, randomized, fixed-dose, placebo …